DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
HUMAN COAGULATION FACTOR IX
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
HUMAN COAGULATION FACTOR IX
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EPOETIN THETA
4
Protein
Approved
Unknown
Unknown
Unknown
Erythropoietin receptor agonist
EPOETIN THETA
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PIPERAZINE
4
Small molecule
Approved
Unknown
Unknown
Helminthiasis
Unknown
PIPERAZINE
×
Maximum Phase:
4
First Approval:
None
UNII:
1RTM4PAL0V
Molecule Type:
Small molecule
Molecular Formula:
C4H10N2
Molecular Weight:
86.14
AlogP:
-0.82
PSA:
24.06
HBD:
2.0
HBA:
#RotB:
0.0
Source:
TECHNETIUM TC-99M SESTAMIBI KIT
4
Small molecule
Approved
OTHER; PREGNANCY AND GYNECOLOGY
INJECTION
Unknown
Unknown
TECHNETIUM TC-99M SESTAMIBI KIT
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NEOMYCIN SULFATE; PREDNISOLONE SODIUM PHOSPHATE
4
Combination
Approved
OTHER
OPHTHALMIC
Unknown
Unknown
NEOMYCIN SULFATE; PREDNISOLONE SODIUM PHOSPHATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BISMUTH SUBCITRATE
4
Small molecule
Unknown
Unknown
Unknown
Lymphoma
Unknown
BISMUTH SUBCITRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
HS813P8QPX
Molecule Type:
Small molecule
Molecular Formula:
C12H13BiO14
Molecular Weight:
590.2
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
COBICISTAT; DARUNAVIR ETHANOLATE; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
COBICISTAT; DARUNAVIR ETHANOLATE; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OCTOXYNOL 9
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
OCTOXYNOL 9
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C28H50O8
Molecular Weight:
514.7
AlogP:
3.87
PSA:
84.84
HBD:
1.0
HBA:
#RotB:
23.0
Source:
CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FLUTRIMAZOLE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
FLUTRIMAZOLE
×
Maximum Phase:
4
First Approval:
None
UNII:
776S0UP252
Molecule Type:
Small molecule
Molecular Formula:
C22H16F2N2
Molecular Weight:
346.38
AlogP:
5.0
PSA:
17.82
HBD:
0.0
HBA:
#RotB:
4.0
Source:
XYLOSE
4
Small molecule
Approved
OTHER
ORAL
Unknown
Unknown
XYLOSE
×
Maximum Phase:
4
First Approval:
None
UNII:
A1TA934AKO
Molecule Type:
Small molecule
Molecular Formula:
C5H10O5
Molecular Weight:
150.13
AlogP:
-2.58
PSA:
90.15
HBD:
4.0
HBA:
#RotB:
0.0
Source:
INSULIN LISPRO-AABC
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
INSULIN LISPRO-AABC
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HYDROXYAMPHETAMINE HYDROBROMIDE; TROPICAMIDE
4
Combination
Approved
OTHER
OPHTHALMIC
Unknown
Unknown
HYDROXYAMPHETAMINE HYDROBROMIDE; TROPICAMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EFAVIRENZ;LAMIVUDINE;TENOFOVIR DISOPROXIL FUMARATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
EFAVIRENZ;LAMIVUDINE;TENOFOVIR DISOPROXIL FUMARATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NIMESULIDE
4
Small molecule
Approved
Unknown
Unknown
Pain; Breast Neoplasms; Arthralgia; Myalgia; Rheumatic Diseases
Unknown
NIMESULIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
V4TKW1454M
Molecule Type:
Small molecule
Molecular Formula:
C13H12N2O5S
Molecular Weight:
308.31
AlogP:
2.76
PSA:
98.54
HBD:
1.0
HBA:
#RotB:
5.0
Source:
SMECTA
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
SMECTA
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HYDROCHLOROTHIAZIDE; LISINOPRIL
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
HYDROCHLOROTHIAZIDE; LISINOPRIL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
abobotulinumtoxinA
4
Unknown
Approved
OTHER
INJECTION
Unknown
Synaptosomal-associated protein 25 inhibitor
abobotulinumtoxinA
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TETANUS IMMUNE GLOBULIN (HUMAN)
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
TETANUS IMMUNE GLOBULIN (HUMAN)
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FLUCLORONIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
FLUCLORONIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
MG258KTA37
Molecule Type:
Small molecule
Molecular Formula:
C24H29Cl2FO5
Molecular Weight:
487.4
AlogP:
3.88
PSA:
72.83
HBD:
1.0
HBA:
#RotB:
2.0
Source:
SILVER NITRATE
4
Small molecule
Approved
Unknown
Unknown
Burns; Pleural Effusion; Chlamydia Infections; Dental Caries; Renal Insufficiency, Chronic
Unknown
SILVER NITRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
95IT3W8JZE
Molecule Type:
Small molecule
Molecular Formula:
AgNO3
Molecular Weight:
169.87
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CARBIDOPA; ENTACAPONE; LEVODOPA
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CARBIDOPA; ENTACAPONE; LEVODOPA
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
XYLOMETAZOLINE
4
Small molecule
Approved
Unknown
Unknown
Common Cold; Eye Manifestations; Nasal Obstruction
Unknown
XYLOMETAZOLINE
×
Maximum Phase:
4
First Approval:
None
UNII:
WPY40FTH8K
Molecule Type:
Small molecule
Molecular Formula:
C16H24N2
Molecular Weight:
244.38
AlogP:
3.15
PSA:
24.39
HBD:
1.0
HBA:
#RotB:
2.0
Source:
TENELIGLIPTIN
4
Small molecule
Approved
Unknown
Unknown
Diabetes Mellitus; Diabetes Mellitus, Type 2
Dipeptidyl peptidase IV inhibitor
TENELIGLIPTIN
×
Maximum Phase:
4
First Approval:
None
UNII:
28ZHI4CF9C
Molecule Type:
Small molecule
Molecular Formula:
C22H30N6OS
Molecular Weight:
426.59
AlogP:
1.57
PSA:
56.64
HBD:
1.0
HBA:
#RotB:
4.0
Source:
LOBAPLATIN
4
Small molecule
Approved
Unknown
Unknown
Neoplasms; Breast Neoplasms; Carcinoma, Squamous Cell; Nasopharyngeal Neoplasms; Small Cell Lung Carcinoma; Carcinoma, Hepatocellular; Esophageal Neoplasms
Unknown
LOBAPLATIN
×
Maximum Phase:
4
First Approval:
None
UNII:
OX5XK1JD8C
Molecule Type:
Small molecule
Molecular Formula:
C9H18N2O3Pt
Molecular Weight:
397.33
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
INFLIXIMAB-DYYB
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
INFLIXIMAB-DYYB
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FISH OILS
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
FISH OILS
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SODIUM PERTECHNETATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
SODIUM PERTECHNETATE
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
NaO4Tc
Molecular Weight:
184.99
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
GLYBURIDE; METFORMIN HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
GLYBURIDE; METFORMIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MERETHOXYLLINE PROCAINE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Sodium channel alpha subunit blocker
MERETHOXYLLINE PROCAINE
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C28H41HgN3O9
Molecular Weight:
764.24
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
FERRIC HEXACYANOFERRATE(II)
4
Small molecule
Approved
OTHER
ORAL
Unknown
Unknown
FERRIC HEXACYANOFERRATE(II)
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ESTRADIOL BENZOATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
ESTRADIOL BENZOATE
×
Maximum Phase:
4
First Approval:
None
UNII:
1S4CJB5ZGN
Molecule Type:
Small molecule
Molecular Formula:
C25H28O3
Molecular Weight:
376.5
AlogP:
5.12
PSA:
46.53
HBD:
1.0
HBA:
#RotB:
2.0
Source:
DESERPIDINE; METHYCLOTHIAZIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
DESERPIDINE; METHYCLOTHIAZIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
257
258
259
260
261
262
263
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA